Susquehanna International Group’s ESSA Pharma EPIX Stock Holding History

Susquehanna International Group’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-29,700	Closed	-$50.5K	–	12728
2025 Q2	$50.5K	Buy	+29,700	New	+$50.1K	﹤0.01%	12111
2024 Q2	–	Sell	-15,700	Closed	-$133K	–	12303
2024 Q1	$133K	Sell	15,700 -3,100	-16%	-$27.1K	﹤0.01%	11008
2023 Q4	$124K	Sell	18,800 -18,500	-50%	-$91.1K	﹤0.01%	11148
2023 Q3	$115K	Buy	37,300 +20,300	+119%	+$58.5K	﹤0.01%	10799
2023 Q2	$45.9K	Sell	17,000 -69,000	-80%	-$202K	﹤0.01%	11372
2023 Q1	$255K	Buy	86,000 +41,900	+95%	+$123K	﹤0.01%	10071
2022 Q4	$111K	Buy	+44,100	New	+$127K	﹤0.01%	10864

Susquehanna International Group's EPIX Position: Q1 2025 in Review

Susquehanna International Group sold out of ESSA Pharma (EPIX) in Q1 2025, closing a stake of 17,704 shares — an estimated $31.7K sold.

Susquehanna International Group first reported a position in EPIX in Q4 2017 and held it in 6 quarters. The position peaked at $296K in Q3 2023. 36 funds tracked by Wall St. Rank hold EPIX as of Q1 2025.

Susquehanna International Group reported no remaining ESSA Pharma position as of Q1 2025 after selling out during the quarter.
Susquehanna International Group sold 17,704 ESSA Pharma shares in Q1 2025, an estimated $31.7K.
Susquehanna International Group first reported a position in ESSA Pharma in Q4 2017 and held it in 6 quarters.
Susquehanna International Group's ESSA Pharma position peaked at $296K in Q3 2023.
36 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2025.

Based on Susquehanna International Group's 13F filing for Q1 2025, filed 14 May 2025.